Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1231-1240 of 1,291) with videos related to

Pageof 130
Sort By:
Cell|May 20, 2021
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoVJohannes F Scheid, Christopher O Barnes, Basak Eraslan, et al.
Parasites & Vectors|December 1, 2018
Monthly variation in the probability of presence of adult Culicoides populations in nine European countries and the implications for targeted surveillanceAna Carolina Cuéllar, Lene Jung Kjær, Andreas Baum, et al.
Bone Marrow Transplantation|April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committeeChristopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Journal of Medical Virology|April 24, 2024
Mpox outbreak in Rio de Janeiro, Brazil: A translational approachGuilherme S Lira, Victor A Ota, Mariana Q S Melo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 TrialJia Xiang Jin, Varun R Ginde, Stefanie Huhn, et al.
The Lancet. Haematology|June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCarmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Blood|July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Pageof 130

Showing results (1231-1240 of 1,291) with videos related to

Sort By:
Pageof 130
Cell|May 20, 2021
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoVJohannes F Scheid, Christopher O Barnes, Basak Eraslan, et al.
Parasites & Vectors|December 1, 2018
Monthly variation in the probability of presence of adult Culicoides populations in nine European countries and the implications for targeted surveillanceAna Carolina Cuéllar, Lene Jung Kjær, Andreas Baum, et al.
Bone Marrow Transplantation|April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committeeChristopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Journal of Medical Virology|April 24, 2024
Mpox outbreak in Rio de Janeiro, Brazil: A translational approachGuilherme S Lira, Victor A Ota, Mariana Q S Melo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 TrialJia Xiang Jin, Varun R Ginde, Stefanie Huhn, et al.
The Lancet. Haematology|June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCarmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Blood|July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Pageof 130